What is BioSig Technologies, Inc.'s net income (NCI)?

BioSig Technologies, Inc. (STEX) reported net income (NCI) of -$37K in Q2 2023.

How has BioSig Technologies, Inc.'s net income (NCI) changed year-over-year?

BioSig Technologies, Inc.'s net income (NCI) decreased by 186.0% year-over-year, from $43K to -$37K.

What does net income (NCI) mean?

The portion of net income attributable to minority shareholders in subsidiaries that are not 100% owned by the parent company. Deducted to arrive at net income attributable to the parent.

BioSig Technologies, Inc. STEX Net Income (NCI)

Discontinued — last reported Q2 '23

Net Income (NCI) at other companies

Bit DigitalBTBT

-$3.61M—

MedtronicMDT

——

GE HealthCare TechnologiesGEHC

——

Segments

By segment

See full

Corporate-$1K-108%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossAttributableToNoncontrollingInterest.

The official record: BioSig Technologies, Inc.’s 10-Q, filed August 14, 2023, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s net income (nci).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s net income (NCI)?: BioSig Technologies, Inc. (STEX) reported net income (NCI) of -$37K in Q2 2023.
How has BioSig Technologies, Inc.'s net income (NCI) changed year-over-year?: BioSig Technologies, Inc.'s net income (NCI) decreased by 186.0% year-over-year, from $43K to -$37K.
What does net income (NCI) mean?: The portion of net income attributable to minority shareholders in subsidiaries that are not 100% owned by the parent company. Deducted to arrive at net income attributable to the parent.